Skip to main content
. 2016 Jun 13;7(30):47134–47144. doi: 10.18632/oncotarget.9972

Figure 6. Analyses of ACE, NHE3, NCC, Ang II, and urinary sodium excretion in the proteinuric patients.

Figure 6

(A) Immunohistochemistry of ACE, NHE3, and NCC demonstrate enhanced tubular expression of these elements in proteinuric kidney. (B) Semi-quantitative measurement of ACE immunoreactivity. (C) Semi-quantitative measurement of NHE3 immunoreactivity. (D) Semi-quantitative measurement of NCC immunoreactivity. (E) Urinary Ang II excretion was stimulated in proteinuric patients. (F) Urinary sodium excretion was reduced in proteinuric patients. The values represent the means ± SDs. For urinary Ang II assay, n = 12–33 in each group. In other experiments, n = 6 in each group. *p < 0.01 vs. control group.